Woodward, Inc. enters the final stretch of Q4 with options traders showing more defensiveness than usual, even as the stock reclaims modest ground after a rough month.
Options positioning has shifted noticeably more protective over the past two weeks. The put/call ratio has climbed to 0.76, about 1.3 standard deviations above its 20-day average of 0.65. That move is sharp rather than gradual: the PCR was running in the 0.55 to 0.58 range through most of September before jumping above 0.75 on September 21 and holding there through the end of the month. The 52-week range runs from 0.05 to 1.04, so the current reading is elevated but not extreme. What is notable is the speed of the shift, which coincides with fresh analyst action on the stock.
The borrowing market tells a very different story, one without any meaningful pressure. Short interest is a modest 1.9% of the free float, up about 1.8% on the week but down 5% over the past month. Availability is exceptionally loose at over 9,300%, meaning there is roughly 93 times more stock available to borrow than is currently borrowed. Borrowing costs are negligible at 0.40%, and while that figure is up roughly 23% week-on-week, the absolute level remains far below anything that would signal squeeze risk. The ORTEX short score of 30 sits in the 74th percentile for low short pressure. Positioning in the lending market is about as unbothered as it gets.
The Street broadly remains constructive, but the direction of travel on price targets has turned more cautious. This week Wells Fargo's David Strauss, whose Overweight rating stays intact, trimmed his target from $440 to $430, the second time RBC Capital has made the same move since July, cutting from $450 to $430 after the Q3 print. Guggenheim started coverage in mid-September with a Buy and a $404 target, adding a fresh voice to the bull camp. Targets across the group cluster in the $404 to $430 range, against a current price of $329.78, leaving mean upside of roughly 33%. The bull case centres on Woodward's breadth of exposure across aerospace and industrial end-markets, its relationships with RTX, GE Aerospace, and Boeing, and its portfolio reshaping through bolt-on acquisitions and divestitures. Bears point to the heavy concentration of sales in aerospace (around 65% of revenue), top-five customer exposure of 36%, and the capital demands of the A350 facility expansion as potential drags on free cash flow. On valuation, the stock trades at 31.6x trailing earnings and 20.1x EV/EBITDA, both up modestly on the week. The PE has compressed from a 30-day peak, down roughly 1.3 points over the month, as the stock pulled back 3.5% in September before recovering about 1.1% this week.
The insider register is net negative over the past 90 days, but the detail matters more than the headline. The largest open-market flows in the recent record belong to Director Daniel Korte, who exercised options and sold shares worth a combined $3.9 million in June at prices around $354 to $357, well above the current $329.78. The only recent filing is an August tax-withholding transaction by CFO William Lacey, a compensation mechanic rather than a discretionary sale. No open-market purchases appear in the trailing 90 days. T. Rowe Price stands out on the institutional side, adding approximately 1.48 million shares in the period through September 1, lifting its stake to 2.84% of shares. BlackRock remains the largest holder at nearly 12% after adding roughly 700,000 shares through August. No 13D activists are on the register.
Retail attention is also running above its own recent norms. The ORTEX alt data layer flags Wikipedia page views at 2.2 standard deviations above their 90-day baseline as of September 22, one of the more elevated readings in the dataset's recent history for this name. That is an attention signal, not a revenue indicator, but it does suggest the stock has drawn more general interest than usual heading into the quarter.
The last earnings print is the backdrop worth keeping in mind. Woodward's Q3 results on July 29 sent the stock down 13.2% on the day and a further 9.1% over the following week, one of the more severe single-day reactions this name has seen. The next report is not due until November 23, leaving 54 days for the options skew and analyst target trajectory to develop further before the market gets a fresh set of numbers to work with.
See the live data behind this article on ORTEX.
Open WWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
